Fumitaka Nagamura

1.4k total citations
53 papers, 1.0k citations indexed

About

Fumitaka Nagamura is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Fumitaka Nagamura has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 13 papers in Oncology and 11 papers in Immunology. Recurrent topics in Fumitaka Nagamura's work include Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (10 papers) and Mesenchymal stem cell research (8 papers). Fumitaka Nagamura is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (10 papers) and Mesenchymal stem cell research (8 papers). Fumitaka Nagamura collaborates with scholars based in Japan, United States and Germany. Fumitaka Nagamura's co-authors include Arinobu Tojo, Shigetaka Asano, Satoshi Takahashi, Jun Ooi, Akira Tomonari, Tohru Iseki, Kaoru Uchimaru, Mariko Eguchi, Nanao Kamada and Yuko Sato and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Fumitaka Nagamura

52 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumitaka Nagamura Japan 16 543 277 238 225 159 53 1.0k
Axel Schulenburg Austria 18 511 0.9× 337 1.2× 235 1.0× 112 0.5× 92 0.6× 41 990
Sylvie François France 21 648 1.2× 433 1.6× 234 1.0× 326 1.4× 107 0.7× 67 1.3k
Roberta H. Adams United States 15 371 0.7× 172 0.6× 148 0.6× 192 0.9× 90 0.6× 53 818
Dolors Costa Spain 21 400 0.7× 190 0.7× 299 1.3× 417 1.9× 64 0.4× 73 1.2k
Mouhab Ayas Saudi Arabia 21 756 1.4× 261 0.9× 316 1.3× 251 1.1× 100 0.6× 92 1.3k
Friedrich Schuening United States 21 617 1.1× 198 0.7× 195 0.8× 174 0.8× 84 0.5× 61 1.0k
Yoshihisa Nagatoshi Japan 18 359 0.7× 249 0.9× 138 0.6× 97 0.4× 90 0.6× 54 889
Walter Feremans Belgium 16 601 1.1× 178 0.6× 177 0.7× 338 1.5× 87 0.5× 58 981
Tohru Iseki Japan 18 986 1.8× 354 1.3× 132 0.6× 338 1.5× 271 1.7× 70 1.3k
J. E. Curtis Canada 18 465 0.9× 231 0.8× 170 0.7× 259 1.2× 89 0.6× 38 1.1k

Countries citing papers authored by Fumitaka Nagamura

Since Specialization
Citations

This map shows the geographic impact of Fumitaka Nagamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumitaka Nagamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumitaka Nagamura more than expected).

Fields of papers citing papers by Fumitaka Nagamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumitaka Nagamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumitaka Nagamura. The network helps show where Fumitaka Nagamura may publish in the future.

Co-authorship network of co-authors of Fumitaka Nagamura

This figure shows the co-authorship network connecting the top 25 collaborators of Fumitaka Nagamura. A scholar is included among the top collaborators of Fumitaka Nagamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumitaka Nagamura. Fumitaka Nagamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nagamura‐Inoue, Tokiko & Fumitaka Nagamura. (2023). Umbilical cord blood and cord tissue banking as somatic stem cell resources to support medical cell modalities. Inflammation and Regeneration. 43(1). 59–59. 9 indexed citations
3.
Nagamura‐Inoue, Tokiko, Seiko Kato, Yuho Najima, et al.. (2022). Immunological influence of serum-free manufactured umbilical cord-derived mesenchymal stromal cells for steroid-resistant acute graft-versus-host disease. International Journal of Hematology. 116(5). 754–769. 6 indexed citations
4.
Fujii, Shin‐ichiro, Toyotaka Kawamata, Kanako Shimizu, et al.. (2022). Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML. Molecular Therapy — Oncolytics. 27. 315–332. 13 indexed citations
5.
Nagamura‐Inoue, Tokiko, Atsuko Takahashi, Yuki Yamamoto, et al.. (2019). Immunosuppressive Diversity of Umbilical Cord-Derived Mesenchymal Stromal Cells. Blood. 134(Supplement_1). 3584–3584. 1 indexed citations
6.
Fujiwara, Noriko, Yuki Shirai, Yuko Saito, et al.. (2017). Qualitative analysis of clinical research coordinators' role in phase I cancer clinical trials. Contemporary Clinical Trials Communications. 8. 156–161. 13 indexed citations
7.
Yoshikawa, Noritada, Noriaki Shimizu, Hiroshi Kobayashi, et al.. (2016). The effects of bolus supplementation of branched-chain amino acids on skeletal muscle mass, strength, and function in patients with rheumatic disorders during glucocorticoid treatment. Modern Rheumatology. 27(3). 508–517. 10 indexed citations
9.
Fukahori, Hiroki, et al.. (2012). Stressor Scale for Clinical Research Coordinators: development and psychometric testing. Journal of Advanced Nursing. 68(7). 1636–1645. 5 indexed citations
10.
Nagayama, Hitomi, Naoyuki Iso-O, Hideki Ohno, et al.. (2010). Gastrointestinal bleeding during anti-angiogenic peptide vaccination in combination with gemcitabine for advanced pancreatic cancer. Clinical Journal of Gastroenterology. 3(6). 307–317. 4 indexed citations
11.
Sato, Aki, Jun Ooi, Satoshi Takahashi, et al.. (2010). Unrelated cord blood transplantation after myeloablative conditioning in adults with advanced myelodysplastic syndromes. Bone Marrow Transplantation. 46(2). 257–261. 19 indexed citations
12.
Vũ, Hoàng Anh, et al.. (2009). Detection of exon 12 type A mutation of NPM1 gene in IMS-M2 cell line. Leukemia Research. 34(2). 261–262. 9 indexed citations
13.
Nagamura‐Inoue, Tokiko, Shunro Kai, Hiroshi Azuma, et al.. (2008). Unrelated cord blood transplantation in CML: Japan Cord Blood Bank Network analysis. Bone Marrow Transplantation. 42(4). 241–251. 19 indexed citations
14.
Konuma, Takaaki, Kaoru Uchimaru, Nobuhiro Ohno, et al.. (2005). Atypical Hypersensitivity to Mosquito Bites without Natural Killer Cell Proliferative Disease in an Adult Patient. International Journal of Hematology. 82(5). 441–444. 5 indexed citations
15.
Tomonari, Akira, Tohru Iseki, Satoshi Takahashi, et al.. (2003). Varicella‐zoster virus infection in adult patients after unrelated cord blood transplantation: a single institute experience in Japan. British Journal of Haematology. 122(5). 802–805. 31 indexed citations
16.
Tomonari, Akira, Satoshi Takahashi, T Iseki, et al.. (2003). Herpes simplex virus infection in adult patients after unrelated cord blood transplantation: a single-institute experience in Japan. Bone Marrow Transplantation. 33(3). 317–320. 8 indexed citations
17.
Ooi, Jun, Tohru Iseki, Satoshi Takahashi, et al.. (2003). Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood. 101(12). 4711–4713. 62 indexed citations
18.
Tomonari, Akira, Tohru Iseki, Jun Ooi, et al.. (2002). Using Related Donors other Than Genotypically HLA-Matched Siblings in Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Disease: A Single Institution Experience in Japan. International Journal of Hematology. 76(4). 354–359. 3 indexed citations
19.
Tojo, Arinobu, et al.. (1998). A Unique Translocation of the TEL Gene in a Case of Acute Myelogenous Leukemia With inv(12)(p13q15). Blood. 92(4). 1454–1455. 15 indexed citations
20.
Takahashi, Shunji, Hitomi Nagayama, Fumitaka Nagamura, et al.. (1994). ドナー白血球輸血(DLT)による致命的移植片対宿主病(GVHD)が移植後急性白血病の再発に及ぼす移植片対白血病(GVL)効果:2症例の報告. Blood. 84(10). 338. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026